companydata.dkcompanydata.dk

Unibio USA ApS: Financial statements 2019

CVR: 38179845

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

Unibio USA ApS (CVR 38179845) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -15,000 and a net result of DKK -12,000 compared with DKK -12,000 the year before. Equity in the 2019 report amounted to DKK 19,000. The solvency ratio was 61.3%.

Gross Profit
DKK -15,000
Profit/Loss
DKK -12,000
Equity
DKK 19,000
Total Assets
DKK 31,000
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019--15K-12K19K0
2018--15K-12K31K0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

Unibio USA ApS: The 2018 annual report is outMay 21, 2019

Unibio USA ApS has published its annual report for 2018. Gross profit came to DKK -15,000, and the net result was DKK -12,000.

About Unibio USA ApS

Unibio USA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of David Richard Henstrom and Søren Olrik Eklund. The company is owned by UNIBIO A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK -20,000 compared with DKK -26,000 the year before. Equity in the 2025 report amounted to DKK 25,000.

Source: annual report 2025, Danish Business Authority

Other financial years